Within the PV group, 37 patients had the JAK2 V617F mutation, 1 patient had the JAK2 exon 12 mutation, and 3 patients did not exhibit any mutations on the JAK2 gene. This evidence concerns the gene JAK2 and acquired polycythemia vera.